| Characteristic | Very unlikely/unlikely | Neutral | Likely/very likely | Don't know/not applicable |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| - | - | - | - | - |
| - | - | - | - | - |
| - | - | - | - | - |
| - | - | - | - | - |
| - | - | - | - | - |
| - | - | - | - | - |
| - | - | - | - | - |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Download
Source
Release date
October 2018
Region
Worldwide, United States
Survey time period
summer 2018
Number of respondents
60 executives
Special properties
30 from biopharma, 30 from medtech companies
Supplementary notes
Original question: "How likely is your company to invest its incremental financial resources in the following activities?"
Citation formats









